Andere Sprachen AbCellera Biologics Inc.

Aktien

A2QKXS

CA00288U1066

ABCL

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 30.04.2024			% 5 Tage	% 1. Jan.
3.77 ^USD	-1.82%		-5.04%	-33.98%

11.03.	AbCellera und Biogen arbeiten zusammen, um Behandlungen für neurologische Krankheiten zu entdecken	MT
11.03.	AbCellera arbeitet mit Biogen zusammen, um therapeutische Antikörper für neurologische Erkrankungen zu entdecken	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

AbCellera Biologics : Corporate Overview	09.04.
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024	08.04.
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024	03.04.
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024	19.03.
AbCellera, Biogen Collaborate to Discover Treatments for Neurological Diseases	11.03.
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions	11.03.
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions	11.03.
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024	05.03.
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024	05.03.
AbCellera Announces Resignation of Board Member	26.02.
AbCellera Announces Resignation of Board Member	23.02.
AbCellera Biologics Inc. Announces Board Changes	23.02.
AbCellera to Present at Upcoming Investor Conferences in March	23.02.
AbCellera Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20.02.
Earnings Flash (ABCL) ABCELLERA BIOLOGICS Reports Fiscal 2023 Revenue $38M	20.02.
AbCellera Reports Full Year 2023 Business Results	20.02.
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024	23.01.
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024	20.12.
Cutting-edge antibody therapy firm, AbCellera, to lay off 10 per cent of workforce	29.11.
Abcellera Biologics, Inc. Announces Reorganization	28.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AbCellera Biologics Inc.

Aktien

A2QKXS

CA00288U1066

ABCL

Andere Sprachen

Filter